Pharmacy Benefit Management

From Drug Benefit News - In the face of cost increases from an emerging category of cholesterol-lowering drugs known as PCSK9 inhibitors, new research posted last week by two different PBMs suggests that plans have work left to do when it comes to encouraging the use of low-cost statins and rechallenging patients at lower doses before they are declared statin intolerant and potentially moved to the higher cost PCSK9s. Read more

From Drug Benefit News - Walgreens Boots Alliance, Inc. (WBA) on Oct. 28 unveiled plans to purchase Rite Aid Corp. for $9 a share, or a total enterprise value of approximately $17.2 billion after factoring in debt, creating what many are calling a retail “behemoth” in the pharmacy space. Given that WBA Executive Vice Chairman and CEO Stefano Pessina this year hinted several times at possible merger and acquisition activity, the proposed deal came as… Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - November 24, 2015
HHS on Nov. 20 held an all-day forum featuring panelists such as consumer and patient advocates, pharmaceutical manufacturers, payers and PBMs. Active discussions took place on the varying factors contributing to rising drug costs and ways to address the complex problem of providing patients with...
By Lauren Flynn Kelly - October 22, 2015
Now that marketing is in full swing for the Medicare 2016 plan year, one thing I’ve noticed as I peruse the updated websites of Prescription Drug Plan (PDP) sponsors — 85% of which offer plans with preferred pharmacy networks — is how clearly they are spelling out the concept of "pharmacies with...
By Angela Maas - October 6, 2015
The FDA recently released long-awaited proposed guidance on naming for biosimilars. But while most of the prerelease discussion focused solely on how biosimilars would be treated, the FDA took a more expansive approach, proposing the addition of a four-letter FDA-designated suffix attached with a...

It's quick and easy to sign up for FREE access to!

Why do I need to register?